Indurthi, chief scientific officer (CSO) at Aldevron, is anticipating RNA technologies to become more complex and sophisticated and is looking forward to seeing more developments in treatments for diseases such as HIV, and various cancers.
Venkata Shravan K. Indurthi, chief scientific officer (CSO) at Aldevron, is anticipating RNA technologies to become more complex and sophisticated and is looking forward to seeing more developments in treatments for diseases such as HIV, and various cancers.